{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:35:02Z","timestamp":1785512102288,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010804","name":"Faculty of Medicine, Prince of Songkla University","doi-asserted-by":"publisher","award":["64-078-3"],"award-info":[{"award-number":["64-078-3"]}],"id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004508","name":"Prince of Songkla University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004508","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.placenta.2024.10.002","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T06:10:33Z","timestamp":1727935833000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Antenatal maternal serum biomarkers as a predictor for placenta accreta spectrum disorders"],"prefix":"10.1016","volume":"158","author":[{"given":"Apichote","family":"Wihakarat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamonnut","family":"Singkhamanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8056-2617","authenticated-orcid":false,"given":"Savitree","family":"Pranpanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2024.10.002_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajog.2017.05.067","article-title":"Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging","volume":"218","author":"Jauniaux","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl 1","key":"10.1016\/j.placenta.2024.10.002_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/aogs.14120","article-title":"Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: a multinational database study","volume":"100","author":"Morlando","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.placenta.2024.10.002_bib3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/aogs.14163","article-title":"Lack of experience is a main cause of maternal death in placenta accreta spectrum patients, Acta","volume":"100","author":"Nieto-Calvache","year":"2021","journal-title":"Obstet. Gynecol. Scand."},{"key":"10.1016\/j.placenta.2024.10.002_bib4","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1097\/AOG.0000000000002983","article-title":"American college of obstetricians and gynecologists, society for maternal-fetal medicine. Obstetric care consensus No. 7: placenta accreta spectrum","volume":"132","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajog.2019.01.233","article-title":"Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis","volume":"221","author":"Jauniaux","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12905-021-01389-z","article-title":"A 5-year experience on perinatal outcome of placenta accreta spectrum disorder managed by cesarean hysterectomy in southern Iranian women","volume":"21","author":"Kasraeian","year":"2021","journal-title":"BMC Wom. Health"},{"key":"10.1016\/j.placenta.2024.10.002_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/01443615.2021.1910638","article-title":"Intraoperative blood volume loss according to gestational age at delivery among pregnant women with placenta accreta spectrum (PAS): an 11-year experience in Songklanagarind Hospital","volume":"42","author":"Maison","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib8","article-title":"Implementation and outcomes of a model of care for placenta accreta spectrum in a community-based private practice","author":"Wagner","year":"2022","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.placenta.2024.10.002_bib9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajog.2019.02.054","article-title":"Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta","volume":"220","author":"Collins","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib10","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2018.09.042","article-title":"Placenta accreta spectrum","volume":"219","author":"Cahill","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ijgo.12408","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.placenta.2024.10.002_bib12","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1080\/14767058.2020.1846699","article-title":"Comparative analysis of ultrasound and MRI in the diagnosis of placenta accreta spectrum","volume":"35","author":"Barzilay","year":"2022","journal-title":"J Matern Fetal Neonatal Med. Med."},{"key":"10.1016\/j.placenta.2024.10.002_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/AOG.0000000000000680","article-title":"Morbidly adherent placenta treatments and outcomes","volume":"125","author":"Bailit","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/aogs.13238","article-title":"Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis","volume":"97","author":"Pagani","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.placenta.2024.10.002_bib15","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/1471-0528.13547","article-title":"Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries","volume":"123","author":"Thurn","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.placenta.2024.10.002_bib16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/uog.24861","article-title":"Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis","volume":"59","author":"De Oliveira Carniello","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib17","first-page":"509","article-title":"Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound","volume":"42","author":"D'Antonio","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1471-0528.12405","article-title":"The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study","volume":"121","author":"Fitzpatrick","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.placenta.2024.10.002_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejogrb.2019.04.032","article-title":"Maternal and neonatal outcomes following a proactive peripartum multidisciplinary management protocol for placenta creta spectrum as compared to the urgent delivery","volume":"237","author":"Stanleigh","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.placenta.2024.10.002_bib20","article-title":"Potential serum biomarkers in prenatal diagnosis of placenta accreta spectrum","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.placenta.2024.10.002_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s43032-020-00319-y","article-title":"Maternal serum VEGF predicts abnormally invasive placenta better than NT-proBNP: a multicenter case-control study","volume":"28","author":"Schwickert","year":"2021","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.placenta.2024.10.002_bib22","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/01443615.2021.1955337","article-title":"Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum","volume":"42","author":"Faraji","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib23","doi-asserted-by":"crossref","first-page":"433.e431","DOI":"10.1016\/j.ajog.2020.03.019","article-title":"Placenta accreta spectrum: biomarker discovery using plasma proteomics","volume":"223","author":"Shainker","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.10.002_bib24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s43032-021-00763-4","article-title":"Placenta percreta presents with neoangiogenesis of arteries with Von Willebrand factor-negative endothelium","volume":"29","author":"Schwickert","year":"2022","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.placenta.2024.10.002_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.placenta.2024.10.002_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","article-title":"Diagnosis FPAFIGO placenta accreta diagnosis and management expert consensus panel. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.placenta.2024.10.002_bib27","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1080\/14767058.2019.1570494","article-title":"Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome","volume":"33","author":"Palacios-Jaraquemada","year":"2020","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.placenta.2024.10.002_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000492829","article-title":"Second trimester biochemical markers as possible predictors of pathological placentation: a retrospective case-control study","volume":"46","author":"Berezowsky","year":"2019","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.placenta.2024.10.002_bib29","first-page":"579","article-title":"Analysis of first and second trimester maternal serum analytes for the prediction of morbidly adherent placenta requiring hysterectomy. Kaohsiung","volume":"32","author":"Oztas","year":"2016","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.placenta.2024.10.002_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1507674","article-title":"Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers","volume":"2018","author":"Bartels","year":"2018","journal-title":"Dis. Markers"},{"key":"10.1016\/j.placenta.2024.10.002_bib31","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/1471-0528.13298","article-title":"First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation","volume":"122","author":"Thompson","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.placenta.2024.10.002_bib32","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1080\/07853890.2021.1999492","article-title":"Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa","volume":"53","author":"Wang","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.placenta.2024.10.002_bib33","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.3109\/14767058.2015.1118044","article-title":"Serum angiogenic profile in abnormal placentation","volume":"29","author":"Biberoglu","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.placenta.2024.10.002_bib34","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/pd.4195","article-title":"Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study","volume":"33","author":"Samuel","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.placenta.2024.10.002_bib35","first-page":"560","article-title":"Increased cell-free fetal DNA fraction in the first trimester: a sign of abnormally invasive placenta? Ultraschall","volume":"41","author":"Wertaschnigg","year":"2020","journal-title":"M\u00e9d."},{"key":"10.1016\/j.placenta.2024.10.002_bib36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/09513590.2019.1576607","article-title":"Human placental lactogen mRNA in maternal plasma play a role in prenatal diagnosis of abnormally invasive placenta: yes or no?","volume":"35","author":"Li","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.placenta.2024.10.002_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijgo.2009.11.013","article-title":"Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta","volume":"109","author":"El Behery","year":"2010","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.placenta.2024.10.002_bib38","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/jog.15330","article-title":"Association between placenta accreta spectrum and third-trimester serum levels of vascular endothelial growth factor, placental growth factor, and soluble Fms-like tyrosine kinase-1: a meta-analysis","volume":"48","author":"Alzoubi","year":"2022","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.placenta.2024.10.002_bib39","article-title":"A simple guide to ultrasound screening for placenta accreta spectrum for improving detection and optimizing management in resource limited settings","author":"Adu-Bredu","year":"2022","journal-title":"Int. J. Gynaecol. Obstet."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424006659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424006659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T08:24:13Z","timestamp":1733991853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400424006659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S0143400424006659"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2024.10.002","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antenatal maternal serum biomarkers as a predictor for placenta accreta spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2024.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}